| |
Tot prot |
IL-1b |
IL-6 |
TNF |
OPG |
OC |
Leptin |
OPN |
PTH |
ACTH |
Insulin |
| IL-6 |
0.487* |
|
|
|
|
|
|
|
|
|
|
| TNF |
0.351* |
0.337** |
0.461* |
|
|
|
|
|
|
|
|
| OPG |
0.542*** |
0.388** |
0.590** |
0.461*** |
|
|
|
|
|
|
|
| OC |
0.531*** |
0.530*** |
|
|
0.516*** |
|
|
|
|
|
|
| Leptin |
0.458*** |
0.386** |
|
|
0.676*** |
0.422** |
|
|
|
|
|
| OPN |
|
|
|
0.521*** |
0.801*** |
0.424** |
0.576*** |
|
|
|
|
| PTH |
|
0.574*** |
|
0.272* |
0.418** |
|
0.455*** |
|
|
|
|
| ACTH |
0.293* |
0.775*** |
|
0.333* |
0.496*** |
0.438** |
0.463*** |
|
0.669*** |
|
|
| Adiponectin |
0.798*** |
0.304* |
0.304* |
0.462*** |
0.716*** |
|
0.618*** |
0.462** |
|
0.367** |
|
| Insulin |
|
0.640* |
|
|
|
|
|
|
|
0.778** |
|
| JIA+ |
|
|
|
|
|
|
|
|
|
0.269* |
0.696* |
| Age |
-0.258* |
|
|
|
|
|
0.327* |
|
|
-0.280* |
|
| Disease duration |
|
|
|
|
|
|
0.332* |
|
|
|
|
| TMJ duration |
-0.298* |
|
|
-0.291* |
|
|
|
|
|
|
|
| Pain |
|
|
|
-0.301* |
-0.269* |
|
|
|
|
|
|
| Pain 1st follow-up |
-0.372** |
-0.314* |
|
|
|
|
|
|
|
-0.426** |
|
| Pain 2nd follow-up |
-0.285* |
|
|
-0.300* |
|
|
|
|
|
-0.366** |
|
| Function 1st follow-up |
-0.290* |
|
|
|
|
|
|
|
|
-0.270* |
|
| Function 2nd follow-up |
-0.313* |
|
|
|
|
|
|
|
|
-0.302* |
|
| TMJ pain palpation |
-0.302* |
|
|
-0.274* |
|
|
|
|
|
-0.308* |
|
*p=0.01-0.05, **p<0.01, ***p<0.001 (Spearman rank order sum). Negative numbers indicate negative correlation. |
